Press Release of the new chef analyst Lưu Đỗ Hoàng Anh about how AstraZeneca protects its vaccine
The Press Release was shared worldwide:
AstraZeneca protects its vaccine, yet the company's shares continue to remain under pressure
In the last few weeks, the public has feared the danger of blood clots possibly caused by AstraZeneca vaccine. However, the company denied the charges last week after examining 17 million people who had been vaccinated in Europe and Great Britain. AstraZeneca's statement was later supported even by the European Medicines Agency (EMA). Nevertheless, Norwegian scientists claim that their research supports the fear of public. And so, after some positive news, AstraZeneca's stock reappeared under pressure.
While AstraZeneca's stock was traded at £71 per share last month on the London Stock Exchange, in the beginning of March its value dropped to £67 per share. Following a series of ups and downs in recent weeks, the value rose to £72 per share in the beginning of last week.
You can read the whole article here.